FDA
-
-
-
-
-
-
-
VivoSim Labs prices $4M private placement at $0.85 per share
-
-
-
-
-
-
-
VivoSim develops AI tool to predict drug-induced diarrhea
-
-
-
-
-
-
-
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
-
-
-
-
-
-
-
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
-
-
-
-
-
-
330,185 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

